Table 2 Disease characteristics of the studied SSc patient’s group
From: Significance of serum Krebs von den Lungen-6 in systemic sclerosis
Characteristic | No (30). | % |
|---|---|---|
Esophgeal dysmotility | ||
Negative | 6 | 20.00% |
Positive | 24 | 80.00% |
Raynaud’s phenomena | ||
Negative | 2 | 6.70% |
Positive | 28 | 93.30% |
Digital ulceration | ||
Negative | 13 | 43.30% |
Positive | 17 | 56.70% |
Digital gangerne | ||
Negative | 25 | 83.30% |
Positive | 5 | 16.70% |
PAH | ||
Mild | 4 | 13.30% |
Moderate | 1 | 3.30% |
No | 25 | 83.30% |
CRP | ||
Negative | 10 | 33.3% |
Positive | 20 | 66.7% |
Serological markers | ||
Anti-ANA (IU/ml) | ||
Negative | 2 | 6.70% |
Positive | 28 | 93.30% |
Anti-Centromere (IU/ml) | ||
Negative | 22 | 73.3% |
Positive | 8 | 26.6% |
Anti-SCL70 (IU/ml) | ||
Negative | 18 | 60% |
Positive | 12 | 40% |
HRCT chest changes | ||
Ground glass | 9 | 30.00% |
Honey combing | 7 | 23.30% |
Nodular | 3 | 10.00% |
Normal | 11 | 36.70% |
Range | Mean ± SD | |
MRSS | 4.00–22.00 | 14.5000 ± 4.95 |
ESR (mm/h) | 20–70 | 41.9667 ± 13.75 |
Pulmonary function tests | ||
FVC (L) | 38.00–130.00 | 78.5667 ± 23.54 |
TLC (L) | 44.00–113.00 | 77.4333 ± 21.22 |
DLCO (L) | 48.00–108.00 | 74.8000 ± 16.34 |